Journal of acquired immune deficiency syndromes : JAIDS
-
J. Acquir. Immune Defic. Syndr. · Dec 2008
Comment Letter Randomized Controlled TrialInfluence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial.
-
J. Acquir. Immune Defic. Syndr. · Dec 2008
HIV seropositivity predicts longer duration of stay and rehospitalization among nonbacteremic febrile injection drug users with skin and soft tissue infections.
Skin/soft tissue infections (SSTIs) are the leading cause of hospital admissions among injection drug users (IDUs). ⋯ Among febrile IDUs with SSTIs, a strong association between HIV seropositivity and health care resource utilization was found. Accordingly, attention to HIV serostatus should be considered in clinical disposition decisions for this vulnerable high-risk population.